Written by 3:59 pm AGORACOM Thought Leadership • One Comment Views: 0

SEC Charges California Biotech For Fraudulent Stock Scheme

For all the heat the SEC has taken lately, you have to give them full marks for cracking down on the micro-cap pump and dump schemes. Here is the latest:

Washington, D.C., Sept. 25, 2008 – The Securities and Exchange Commission today charged Rancho Cordova, Calif.-based Telomolecular Corp. and two of its former executives for their roles in a stock scheme based on false claims to investors that the biotechnology start-up company was on the verge of financial and scientific success in developing anti-aging treatments and cancer cures. (FULL STORY)

SMALL-CAP AND MICRO-CAP CEO’S HAVE TO MAKE REALISTIC CLAIMS

The Telomolecular offense isn’t as far off the beaten path as you would think. We still continue to receive calls from companies that make some pretty outrageous claims. Yes, some are complete scams but some are from well-meaning CEO’s that have simply fallen too far in love with their company and waayyyy overestimate their capabilities.

If you fall into the latter, don’t think you’re too far off from getting yourself busted by the SEC. Having evil intentions isn’t a necessary pre-requisite to charges being laid by the SEC.

“Companies raising capital from investors need to provide realistic and
accurate information
about their resources and prospects for future
success,” said Marc Fagel, Director of the SEC’s San Francisco Regional Office.”

CONCLUSION

Keep it real. There is nothing wrong with being super enthusiastic about your product or service – but you have to separate that from your public communications and performance expectations. Google wasn’t built in a day, so neither will your company.

Regards,
George

Visited 1 times, 1 visit(s) today

Last modified: July 13, 2026